Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fuji
Merck
Chinese Patent Office
Farmers Insurance
Healthtrust
Colorcon
US Department of Justice
Daiichi Sankyo
Baxter

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,265,893

« Back to Dashboard

Summary for Patent: 9,265,893
Title:Injection button
Abstract: A push button connection for an injection device comprising a push button (10) and a driving part (20). The two parts of the push button connection are mounted to each other and is relatively rotatable to each other. In order to minimize the friction occurring between the push button and the driving part when relatively rotated forces are transmitted via a pivot bearing (18, 22). In order also to minimize the effect of forces appearing dislocated from the center line a number of radial bearings (13, 23; 14, 25) having a little friction diameter is provided.
Inventor(s): Hansen; Torben Stroem (Copenhagen V, DK), Wielandt; Jakob Oest (Copenhagen N, DK), Groth; Lars Moerch (Fredensborg, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:12/525,976
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 9,265,893

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novo Nordisk Inc LEVEMIR FLEXPEN insulin detemir recombinant INJECTABLE;SUBCUTANEOUS 021536-002 Jun 16, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Novo Nordisk Inc NOVOLOG FLEXPEN insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986-003 Jan 19, 2001 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Novo Nordisk Inc NOVOLOG MIX 70/30 FLEXPEN insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021172-004 May 3, 2002 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Novo Nordisk Inc VICTOZA liraglutide recombinant SOLUTION;SUBCUTANEOUS 022341-001 Jan 25, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,265,893

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
07101729Feb 5, 2007
PCT Information
PCT FiledJanuary 21, 2008PCT Application Number:PCT/EP2008/050624
PCT Publication Date:August 14, 2008PCT Publication Number: WO2008/095762

International Patents Family Members for US Patent 9,265,893

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 2010517650 ➤ Try a Free Trial
Spain 2351778 ➤ Try a Free Trial
European Patent Office 2109474 ➤ Try a Free Trial
Denmark 2109474 ➤ Try a Free Trial
Germany 602008002896 ➤ Try a Free Trial
China 101605569 ➤ Try a Free Trial
Canada 2676810 ➤ Try a Free Trial
Brazil PI0806854 ➤ Try a Free Trial
Australia 2008213084 ➤ Try a Free Trial
Austria 483487 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Queensland Health
Cerilliant
Fish and Richardson
Johnson and Johnson
US Army
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot